Experienced in Systemic Sclerosis (SSc)

Dr. Bela Patel

Pulmonary Medicine
UT Physicians Internal Medicine - Texas Medical Center
6410 Fannin St, 
Houston, TX 
Experienced in Systemic Sclerosis (SSc)
UT Physicians Internal Medicine - Texas Medical Center
6410 Fannin St, 
Houston, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Bela Patel is a Pulmonary Medicine provider in Houston, Texas. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Severe Acute Respiratory Syndrome (SARS), COVID-19, Pulmonary Hypertension, and Acute Interstitial Pneumonia.

Her clinical research consists of co-authoring 76 peer reviewed articles and participating in 16 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article and participated in 1 clinical trial in the study of Systemic Sclerosis (SSc).

Specialties
Pulmonary Medicine
Licenses
Internal Medicine in TX
Hospital Affiliations
Memorial Hermann - Texas Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

UT Physicians Internal Medicine - Texas Medical Center
6410 Fannin St, Houston, TX 77030
Call: 832-325-7100

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

16 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: February 06, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells (hMSCs) for the Treatment of Acute Respiratory Distress Syndrome
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells (hMSCs) for the Treatment of Acute Respiratory Distress Syndrome
Enrollment Status: Completed
Publish Date: December 04, 2025
Intervention Type: Biological
Study Drugs: Human Mesenchymal Stromal Cells, Cell Reconstitution Media
Study Phase: Phase 2
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Completed
Publish Date: June 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Enrollment Status: Active_not_recruiting
Publish Date: March 28, 2025
Intervention Type: Drug
A Phase 2 Study of BIO 300 Oral Suspension in Discharged COVID-19 Patients
A Phase 2 Study of BIO 300 Oral Suspension in Discharged COVID-19 Patients
Enrollment Status: Active_not_recruiting
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: BIO 300
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
Enrollment Status: Completed
Publish Date: September 23, 2024
Intervention Type: Biological, Drug
Study Drugs: Otilimab, Standard of Care
Study Phase: Phase 2
Randomized Master Protocol for Immune Modulators for Treating COVID-19
Randomized Master Protocol for Immune Modulators for Treating COVID-19
Enrollment Status: Completed
Publish Date: September 25, 2023
Intervention Type: Drug
Study Drugs: Infliximab, Abatacept, Remdesivir, Cenicriviroc
Study Phase: Phase 3
Comparison of the Efficacy and Safety of Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune) Plasma Among Outpatients With Symptomatic COVID-19
Comparison of the Efficacy and Safety of Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune) Plasma Among Outpatients With Symptomatic COVID-19
Enrollment Status: Completed
Publish Date: June 02, 2023
Intervention Type: Biological
Study Drugs: Anti-COVID-19 Plasma, Anti-COVID-19 Non-Immune Plasma
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Other, Biological, Drug, Diagnostic test
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Convalescent Plasma to Stem Coronavirus: A Randomized, Blinded Phase 2 Study Comparing the Efficacy and Safety Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune Plasma) Among Adults Exposed to COVID-19
Convalescent Plasma to Stem Coronavirus: A Randomized, Blinded Phase 2 Study Comparing the Efficacy and Safety Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune Plasma) Among Adults Exposed to COVID-19
Enrollment Status: Completed
Publish Date: April 26, 2022
Intervention Type: Biological
Study Drugs: Anti-COVID-19 Plasma, Anti-COVID-19 Non-Immune Plasma
Study Phase: Phase 2
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
Enrollment Status: Completed
Publish Date: December 14, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 15 Less Clinical Trials
Similar Doctors
Experienced in Systemic Sclerosis (SSc)
Dr. Sandeep Sahay
Pulmonary Medicine | Intensive Care Medicine
Experienced in Systemic Sclerosis (SSc)
Dr. Sandeep Sahay
Pulmonary Medicine | Intensive Care Medicine

Tmh Physician Associates PLLC

7575 San Felipe St, Suite 155, 
Houston, TX 
 (6.7 miles away)
713-266-9955
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sandeep Sahay is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Houston, Texas. Dr. Sahay is rated as an Elite provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Acute Interstitial Pneumonia, Lung Transplant, and Embolectomy. Dr. Sahay is currently accepting new patients.

Experienced in Systemic Sclerosis (SSc)
Dr. Zeenat Safdar
Pulmonary Medicine
Experienced in Systemic Sclerosis (SSc)
Dr. Zeenat Safdar
Pulmonary Medicine

Tmh Physician Associates PLLC

6565 Fannin St, 
Houston, TX 
 (0.3 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Zeenat Safdar is a Pulmonary Medicine provider in Houston, Texas. Dr. Safdar is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Pulmonary Fibrosis, Acute Interstitial Pneumonia, and Lung Transplant. Dr. Safdar is currently accepting new patients.

Experienced in Systemic Sclerosis (SSc)
Dr. Howard J. Huang
Pulmonary Medicine
Experienced in Systemic Sclerosis (SSc)
Dr. Howard J. Huang
Pulmonary Medicine

Tmh Physician Associates PLLC

6565 Fannin St, 
Houston, TX 
 (0.3 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Howard Huang is a Pulmonary Medicine provider in Houston, Texas. Dr. Huang is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Idiopathic Pulmonary Fibrosis, COVID-19, Pulmonary Fibrosis, Lung Transplant, and Gastrostomy. Dr. Huang is currently accepting new patients in some locations.

VIEW MORE SYSTEMIC SCLEROSIS (SSC) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Patel's expertise for a condition
ConditionClose
      • Advanced
      • Acute Interstitial Pneumonia
        Dr. Patel is
        Advanced
        . Learn about Acute Interstitial Pneumonia.
        See more Acute Interstitial Pneumonia experts
      • COVID-19
        Dr. Patel is
        Advanced
        . Learn about COVID-19.
        See more COVID-19 experts
      • Interstitial Lung Disease
        Dr. Patel is
        Advanced
        . Learn about Interstitial Lung Disease.
        See more Interstitial Lung Disease experts
      • Pneumonia
        Dr. Patel is
        Advanced
        . Learn about Pneumonia.
        See more Pneumonia experts
      • Pulmonary Hypertension
        Dr. Patel is
        Advanced
        . Learn about Pulmonary Hypertension.
        See more Pulmonary Hypertension experts
      • Severe Acute Respiratory Syndrome (SARS)
        Dr. Patel is
        Advanced
        . Learn about Severe Acute Respiratory Syndrome (SARS).
        See more Severe Acute Respiratory Syndrome (SARS) experts
      • Experienced
      • Acute Respiratory Distress Syndrome (ARDS)
        Dr. Patel is
        Experienced
        . Learn about Acute Respiratory Distress Syndrome (ARDS).
        See more Acute Respiratory Distress Syndrome (ARDS) experts
      • Bronchiectasis
        Dr. Patel is
        Experienced
        . Learn about Bronchiectasis.
        See more Bronchiectasis experts
      • Cerebral Hypoxia
        Dr. Patel is
        Experienced
        . Learn about Cerebral Hypoxia.
        See more Cerebral Hypoxia experts
      • Heart Failure with Preserved Ejection Fraction (HFpEF)
        Dr. Patel is
        Experienced
        . Learn about Heart Failure with Preserved Ejection Fraction (HFpEF).
        See more Heart Failure with Preserved Ejection Fraction (HFpEF) experts
      • Hypersensitivity Pneumonitis
        Dr. Patel is
        Experienced
        . Learn about Hypersensitivity Pneumonitis.
        See more Hypersensitivity Pneumonitis experts
      • Idiopathic Pulmonary Fibrosis
        Dr. Patel is
        Experienced
        . Learn about Idiopathic Pulmonary Fibrosis.
        See more Idiopathic Pulmonary Fibrosis experts
      View All 13 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.